311 related articles for article (PubMed ID: 12075357)
21. Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues.
Shimada N; Suzuki T; Inoue S; Kato K; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
Mol Cell Endocrinol; 2004 Apr; 218(1-2):147-53. PubMed ID: 15130519
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs.
Orimo A; Inoue S; Ikeda K; Noji S; Muramatsu M
J Biol Chem; 1995 Oct; 270(41):24406-13. PubMed ID: 7592654
[TBL] [Abstract][Full Text] [Related]
23. Effects of partner proteins on BCA2 RING ligase activity.
Bacopulos S; Amemiya Y; Yang W; Zubovits J; Burger A; Yaffe M; Seth AK
BMC Cancer; 2012 Feb; 12():63. PubMed ID: 22315970
[TBL] [Abstract][Full Text] [Related]
24. A death-associated protein kinase (DAPK)-interacting protein, DIP-1, is an E3 ubiquitin ligase that promotes tumor necrosis factor-induced apoptosis and regulates the cellular levels of DAPK.
Jin Y; Blue EK; Dixon S; Shao Z; Gallagher PJ
J Biol Chem; 2002 Dec; 277(49):46980-6. PubMed ID: 12351649
[TBL] [Abstract][Full Text] [Related]
25. SAG/ROC/Rbx/Hrt, a zinc RING finger gene family: molecular cloning, biochemical properties, and biological functions.
Sun Y; Tan M; Duan H; Swaroop M
Antioxid Redox Signal; 2001 Aug; 3(4):635-50. PubMed ID: 11554450
[TBL] [Abstract][Full Text] [Related]
26. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
27. Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor.
Das N; Wang J; Dey SK
Mol Reprod Dev; 1997 Apr; 46(4):499-506. PubMed ID: 9094097
[TBL] [Abstract][Full Text] [Related]
28. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
29. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts.
Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W
EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.
Nyormoi O; Wang Z; Doan D; Ruiz M; McConkey D; Bar-Eli M
Mol Cell Biol; 2001 Aug; 21(15):4856-67. PubMed ID: 11438643
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic anti-cancer targets upstream of the proteasome.
Nalepa G; Wade Harper J
Cancer Treat Rev; 2003 May; 29 Suppl 1():49-57. PubMed ID: 12738243
[TBL] [Abstract][Full Text] [Related]
32. hRUL138, a novel human RNA-binding RING-H2 ubiquitin-protein ligase.
Kreft SG; Nassal M
J Cell Sci; 2003 Feb; 116(Pt 4):605-16. PubMed ID: 12538761
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome.
Berse M; Bounpheng M; Huang X; Christy B; Pollmann C; Dubiel W
J Mol Biol; 2004 Oct; 343(2):361-70. PubMed ID: 15451666
[TBL] [Abstract][Full Text] [Related]
35. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
Nakayama KI; Hatakeyama S; Nakayama K
Biochem Biophys Res Commun; 2001 Apr; 282(4):853-60. PubMed ID: 11352628
[TBL] [Abstract][Full Text] [Related]
37. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.
Charrasse S; Carena I; Brondani V; Klempnauer KH; Ferrari S
Oncogene; 2000 Jun; 19(26):2986-95. PubMed ID: 10871850
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-mediated protein modification and degradation.
Schwartz AL; Ciechanover A
Am J Respir Cell Mol Biol; 1992 Nov; 7(5):463-8. PubMed ID: 1329865
[TBL] [Abstract][Full Text] [Related]
39. The 26S proteasome system degrades the ERM transcription factor and regulates its transcription-enhancing activity.
Baert JL; Beaudoin C; Monte D; Degerny C; Mauen S; de Launoit Y
Oncogene; 2007 Jan; 26(3):415-24. PubMed ID: 16832340
[TBL] [Abstract][Full Text] [Related]
40. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.
Orimo A; Inoue S; Minowa O; Tominaga N; Tomioka Y; Sato M; Kuno J; Hiroi H; Shimizu Y; Suzuki M; Noda T; Muramatsu M
Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12027-32. PubMed ID: 10518570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
